Galera Therapeutics, INC. (GRTX) — DEF 14A Filings
All DEF 14A filings from Galera Therapeutics, INC.. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (2)
-
Galera Therapeutics Files Definitive Proxy Statement
— Jan 24, 2025 Risk: low
Galera Therapeutics, Inc. filed its definitive proxy statement on January 24, 2025, for its annual meeting. The filing, under the 1934 Act, concerns the solicit -
Galera Therapeutics Files Definitive Proxy Statement
— Sep 3, 2024 Risk: low
Galera Therapeutics, Inc. filed its definitive proxy statement (DEF 14A) on September 3, 2024, for its annual meeting of stockholders scheduled for October 17,
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX